SAR

Clinical trials for SAR explained in plain language.

Never miss a new study

Get alerted when new SAR trials appear

Sign up with your email to follow new studies for SAR, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Not yet recruiting 1

New allergy shot under safety spotlight

Symptom relief Not yet recruiting

This study will test the safety of a new biologic drug called stapokibart, given as a shot, in 400 adults with seasonal allergic rhinitis (SAR). Participants are already prescribed the drug by their doctor. The main goal is to track any side effects. This is an open-label study, …

Matched conditions: SAR

Sponsor: Chengdu Kangnuoxing Biopharma,Inc. • Aim: Symptom relief

Last updated Jun 27, 2026 11:00 UTC

SAR

Get alerted when new SAR trials appear

New allergy shot under safety spotlight